"Developing Optimal Pricing & Reimbursement Strategies in Today’s Global Healthcare Markets"
Including Pharma, Biotech & Medtech Products
Presenter:
Christian Schuler
Partner and Head of Life Science, Simon – Kucher & Partners
In today’s environment of accelerating health care costs, key stakeholders are increasing pricing pressure on pharmaceutical, biotech and medtech companies. While ultimately all stakeholders determine market access & product use by weighing product value and price relative to competitors, they have country-specific approaches and tools for controlling healthcare costs. Developing a robust national or international pricing strategy requires understanding the country-specific nuances of each stakeholder group on national, regional and local levels and market experience to determine how pricing decisions will impact the uptake of a Life Sciences Innovation.
This workshop will train you on how to approach these challenges with thoughtful discussions on the implications of healthcare reform in the United States, strategies for improving payer contracting in the US, evolving international reimbursement landscapes, key healthcare trends, value-based pricing research methodologies, and tips for developing internationally robust pricing & reimbursement strategies with the goal of optimizing the launch strategy for Life Sciences innovations in today’s healthcare market.
In this workshop you will learn how to:
-
Approach value based pricing for healthcare innovations
-
Understand and avoid common pitfalls when pricing Life Sciences innovations
-
Understand pricing & reimbursement approaches of key global healthcare systems (e.g. US, Germany, France & Japan)
-
Use contracting with US Managed Care effectively
-
Think like a key stakeholder (payers, physicians, patients). What do they value? What methods, tools and thresholds do they employ?
-
Employ state-of-the-art research methodologies for successful pricing decisions and strategies
-
Develop international pricing strategies that account for price referencing and parallel trade
Christian Schuler joined Simon-Kucher & Partners 11 years ago.
He specializes in strategic pharmaceutical marketing, value-to-customer, market entry strategies, P&R strategies, innovative pricing strategies, product lifecycle strategies, generics defense strategies and market forecasting.
Since joining SKP, Mr. Schuler has conducted in-depth research and data analysis for life science companies and developed various national and international pricing and market entry strategies for new chemical entities, medical devices and scientific equipment.
Mr. Schuler received his degree in Business Administration with a focus on marketing, international management and chemical technology from the University of Mannheim in 1998.